Inhibited the viability of cervical cancer cells in a dose-dependent manner via stimulating mitochondrial-mediated apoptosis. Stimulated cell apoptosis by suppressing NF-kappa B (NF-kB) activity, which was also affected by punicalagin, blocking cancer cell progression. The gene discussed is NFKB1; the disease is cervical cancer.